Dominguez, Kristina .

HRN: 28-47-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2026
CO-AMOXICLAV 625MG (TAB)
02/16/2026
02/23/2026
ORAL
625mg
BID
PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: